These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9536558)

  • 1. Postmenopausal HRT--a role for a safe antioestrogen.
    Williams GM
    Int J Clin Pract; 1998; 52(1):5. PubMed ID: 9536558
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal HRT--a role for a safe antioestrogen.
    Jackson I; Steinberg M; Orton TC
    Int J Clin Pract; 1998; 52(1):5-6. PubMed ID: 9536559
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T; Vehmanen L; Elomaa I; Välimäki M; Mäkelä P; Blomqvist C
    Br J Cancer; 2001 Apr; 84(8):1047-51. PubMed ID: 11308252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen for the prevention of breast cancer.
    Greenspan EM
    Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    DeGregorio MW
    J Natl Cancer Inst; 1999 Mar; 91(5):474-5. PubMed ID: 10070949
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Mäenpää J; Ellmén J; Pasanen T; Kaukonen M
    J Natl Cancer Inst; 1999 Jun; 91(11):972-3. PubMed ID: 10359551
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.
    Pukkala E; Kyyrönen P; Sankila R; Holli K
    Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Williams GM
    J Natl Cancer Inst; 1999 Apr; 91(8):722-3. PubMed ID: 10218512
    [No Abstract]   [Full Text] [Related]  

  • 10. Toremifene: an evaluation of its safety profile.
    Harvey HA; Kimura M; Hajba A
    Breast; 2006 Apr; 15(2):142-57. PubMed ID: 16289904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of an ideal hormone replacement therapy for women.
    Tonetti DA; Jordan VC
    Mol Carcinog; 1996 Nov; 17(3):108-11. PubMed ID: 8944069
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
    Timmerman D; Neven P; Deprest J; Konstantinović ML; Vergote I
    Cancer; 2003 Jul; 98(2):431-2; author reply 432-3. PubMed ID: 12872366
    [No Abstract]   [Full Text] [Related]  

  • 14. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups.
    Schlesinger C; Kamoi S; Ascher SM; Kendell M; Lage JM; Silverberg SG
    Int J Gynecol Pathol; 1998 Oct; 17(4):302-11. PubMed ID: 9785130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    O'Regan RM; Cisneros A; England GM; MacGregor JI; Muenzner HD; Assikis VJ; Bilimoria MM; Piette M; Dragan YP; Pitot HC; Chatterton R; Jordan VC
    J Natl Cancer Inst; 1998 Oct; 90(20):1552-8. PubMed ID: 9790548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal HRT--a role for tamoxifen?
    Jackson G
    Int J Clin Pract; 1997; 51(5):267. PubMed ID: 9489081
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen and endometrial neoplasia.
    Barakat RR
    Clin Obstet Gynecol; 1996 Sep; 39(3):629-40. PubMed ID: 8862888
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive endometrial polyp after tamoxifen therapy.
    Divers MJ
    Br J Clin Pract; 1995; 49(5):275-6. PubMed ID: 7492471
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometrial carcinoma can develop in patients on tamoxifen therapy.
    Omar SZ; Sivanesaratnam V
    Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.